General Information

MaintermOLEAMIDE
CAS Reg.No.(or other ID)301-02-0
Regnum 175.105
175.300
178.3910
179.45
181.28

From www.fda.gov

Computed Descriptors

Download SDF
2D Structure
CID5283387
IUPAC Name(Z)-octadec-9-enamide
InChIInChI=1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H2,19,20)/b10-9-
InChI KeyFATBGEAMYMYZAF-KTKRTIGZSA-N
Canonical SMILESCCCCCCCCC=CCCCCCCCC(=O)N
Molecular FormulaC18H35NO
Wikipediaoleamide

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight281.484
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count15
Complexity236.0
CACTVS Substructure Key Fingerprint A A A D c f B 6 I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A H g A Q A A A A C A C B g A A C A A B A A A C I A C F S E A A A A A A g A A A I C A E A A A g A A B I A g Q A A A A A A k A A I A A M Y i I C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = =
Topological Polar Surface Area43.1
Monoisotopic Mass281.272
Exact Mass281.272
XLogP3None
XLogP3-AA6.6
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count20
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


Food Additives Biosynthesis/Degradation


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9972
Human Intestinal AbsorptionHIA+1.0000
Caco-2 PermeabilityCaco2+0.6255
P-glycoprotein SubstrateNon-substrate0.6264
P-glycoprotein InhibitorNon-inhibitor0.7291
Non-inhibitor0.9452
Renal Organic Cation TransporterNon-inhibitor0.8756
Distribution
Subcellular localizationLysosome0.4638
Metabolism
CYP450 2C9 SubstrateNon-substrate0.8241
CYP450 2D6 SubstrateNon-substrate0.7486
CYP450 3A4 SubstrateNon-substrate0.6255
CYP450 1A2 InhibitorInhibitor0.9107
CYP450 2C9 InhibitorNon-inhibitor0.9071
CYP450 2D6 InhibitorNon-inhibitor0.9231
CYP450 2C19 InhibitorNon-inhibitor0.8650
CYP450 3A4 InhibitorNon-inhibitor0.9101
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.7462
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.9685
Non-inhibitor0.8939
AMES ToxicityNon AMES toxic0.9131
CarcinogensNon-carcinogens0.7076
Fish ToxicityHigh FHMT0.6884
Tetrahymena Pyriformis ToxicityHigh TPT0.9785
Honey Bee ToxicityLow HBT0.6230
BiodegradationNot ready biodegradable0.6251
Acute Oral ToxicityIII0.6537
Carcinogenicity (Three-class)Non-required0.6608

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility-2.1626LogS
Caco-2 Permeability0.9977LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity2.0712LD50, mol/kg
Fish Toxicity1.0950pLC50, mg/L
Tetrahymena Pyriformis Toxicity0.2431pIGC50, ug/L

From admetSAR


Taxonomic Classification

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClassFatty Acyls
SubclassFatty amides
Intermediate Tree NodesNot available
Direct ParentFatty amides
Alternative Parents
Molecular FrameworkAliphatic acyclic compounds
SubstituentsFatty amide - Primary carboxylic acid amide - Carboxamide group - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Carbonyl group - Aliphatic acyclic compound
DescriptionThis compound belongs to the class of organic compounds known as fatty amides. These are carboxylic acid amide derivatives of fatty acids, that are formed from a fatty acid and an amine.

From ClassyFire